Israel
Tuberculosis profile
Population  2012 7.6 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.017 (0.017–0.018) 0.23 (0.22–0.23)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.02–0.04)
Prevalence  (includes HIV+TB) 0.85 (0.4–1.5) 11 (5.2–19)
Incidence  (includes HIV+TB) 0.58 (0.51–0.66) 7.6 (6.7–8.6)
Incidence (HIV+TB only) 0.022 (0.019–0.025) 0.29 (0.25–0.33)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 142 (29) Relapse 8 (73)
Smear-negative 200 (40) Treatment after failure 0 (0)
Smear-unknown / not done 54 (11) Treatment after default 0 (0)
Extrapulmonary 102 (20) Other 3 (27)
Other 0 (0)      
Total new 498   Total retreatment 11  
           
Other (history unknown) 0        
Total new and relapse 506   Total cases notified 509  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.4 2.9 1.4
Age < 15 0 17 2
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 77   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 79  
Retreatment 50  
TB/HIV 2012 Number (%)
TB patients with known HIV status 503 (99)
HIV-positive TB patients 16 (3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 4.7 (2.7–7.7) 33 (4.3–78)
MDR-TB cases among notified pulmonary
TB cases
19 (11–30) 4 (0–9)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 318 (98%) 6 (55%) 324
Laboratory-confirmed MDR-TB cases 15 2 17
Patients started on MDR-TB treatment     17
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-21 Data: www.who.int/tb/data